Safety Study of P28GST Treatment in Crohn's Disease Patients

NCT02281916 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Crohn's Ileocolitis

Interventions

DRUG: P28GST

Sponsor

University Hospital, Lille

Collaborators

[object Object]
[object Object]